Best Cholangiocarcinoma (Bile Duct Cancer) Hospitals in Turkey

With advanced hepatobiliary oncology infrastructure, Medicana Bursa Hospital offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 2017, the JCI, ISO accredited hospital is located in Bursa, Turkey, and has 300 beds.

For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.

Acibadem Bakirkoy Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2000, the JCI accredited hospital is situated in Istanbul, Turkey, with 102 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Acibadem Hospital Taksim provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2015, the JCI accredited hospital is based in Istanbul, Turkey, with 99 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

At Acibadem Maslak Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2009, the JCI accredited hospital is located in Istanbul, Turkey, and has 364 beds.

Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.

At Acibadem Fulya Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2006, the JCI accredited hospital is located in Istanbul, Turkey, and has 138 beds.

Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.

With advanced hepatobiliary oncology infrastructure, Medical Park Gebze Hospital offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 2015, the JCI accredited hospital is located in Kocaeli, Turkey, and has 120 beds.

For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.

At Guven Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 1975, the GHA accredited hospital is located in Ankara, Turkey, and has 254 beds.

Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.

Can Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2017, the JCI, NABH accredited hospital is based in Izmir, Turkey, with 95 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

Medipol Mega University Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2012, the JCI accredited hospital is located in Istanbul, Turkey, with 810 beds, providing comprehensive cancer care for local and international patients.

Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.

Medicana Haznedar Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1995, the ISO, JCI accredited hospital is based in Istanbul, Turkey, with 120 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

Anadolu Medical Center provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2005, the JCI, ISO accredited hospital is based in Kocaeli, Turkey, with 268 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

I.A.U VM Medical Park Florya Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2017, the JCI accredited hospital is situated in Istanbul, Turkey, with 300 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Medical Park Bahcelievler Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2015, the JCI accredited hospital is based in Istanbul, Turkey, with 242 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

Biruni University Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2016, the JCI accredited hospital is situated in Istanbul, Turkey, with 617 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Medstar Antalya Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2009, the JCI accredited hospital is located in Ankara, Turkey, with 124 beds, providing comprehensive cancer care for local and international patients.

Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.